West Financial Advisors LLC Purchases Shares of 55 UnitedHealth Group Incorporated (NYSE:UNH)

West Financial Advisors LLC bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 55 shares of the healthcare conglomerate’s stock, valued at approximately $32,000.

A number of other hedge funds also recently bought and sold shares of UNH. Delta Financial Group Inc. lifted its stake in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after acquiring an additional 17 shares during the period. Signature Resources Capital Management LLC increased its position in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the period. Saxony Capital Management LLC lifted its holdings in UnitedHealth Group by 3.5% in the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after buying an additional 18 shares during the period. GoalVest Advisory LLC grew its holdings in shares of UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after acquiring an additional 18 shares during the period. Finally, Fiduciary Group LLC lifted its stake in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after purchasing an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $591.22 on Thursday. The business has a fifty day moving average of $582.68 and a 200 day moving average of $529.13. The firm has a market capitalization of $545.94 billion, a P/E ratio of 36.14, a PEG ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the prior year, the company posted $6.14 earnings per share. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Royal Bank of Canada raised their price objective on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, September 25th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price target for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Truist Financial lifted their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, TD Cowen lifted their price target on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $614.17.

Insider Buying and Selling at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.